Skip to content
Blerp – Lifestyle
Author:
Alligator Bioscience
Nomination Committee of Alligator Bioscience Proposes New Board and Reduced Fees Ahead of Extraordinary General Meeting on 27 November 2026
November 13, 2026
Nomination Committee Appointed in Respect of AGM 2027 in Alligator Bioscience AB
November 3, 2026
Alligator Bioscience Signs Agreement To Sell Mitazalimab to Biossil
October 31, 2026
Change in Number of Shares and Votes in Alligator Bioscience AB
October 30, 2026
The Board of Directors of Alligator Bioscience Proposes a Reverse Share Split of Ordinary Shares
October 27, 2026
Notice of Extraordinary General Meeting in Alligator Bioscience AB
October 27, 2026
Alligator Bioscience AB Reports Financial Results for The Period 1 January – 30 September 2026 and Provides a Business Update
October 22, 2026
Invitation to Alligator Bioscience’s Interim Report Call on 22 October 2026
October 15, 2026
Alligator Bioscience Appoints Johan Giléus as CEO – Søren Bregenholt To Step Down at Year-End
October 4, 2026
Alligator Bioscience Carries Out a Directed Issue of Warrants to Fenja Capital in Connection with The Completed Rights Issue
September 29, 2026
1
2
Next Page
→